Ipsen SA
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Filings
75 filings
- Ipsen initiates a new share buy-back programShare buybackFR
- Ipsen – Half year statement – 2025 12 31Share buybackFR
- Ipsen - Bilan semestriel - 30 juin 2025Share buybackFrench
About
- ISIN
- FR0010259150
- Ticker
- IPN
- LEI
- 549300M6SGDPB4Z94P11
- Sector
- Health care
- Founded
- 1929
- Employees
- 5,300
- Country of registration
- FR
- Last filing
- 03/08/2026, 18:00
Description from Wikidata, CC0 licence.
Filing history
Filings per month
28
Sept 23May 24Jan 25Sept 25Aug 26
Document types
Across the whole archive